Pharmalot

Pharmalot

Pharmalittle: Step forward for ovarian cancer drugs; Pelosi’s drug pricing plan could hit hospitals hard

By Elizabeth Cooney

Pharmalot

Avanir to pay $116 million to settle bribery charges, while two docs and former sales reps are indicted

By Ed Silverman

Pharmalot

Mylan pays $30 million to settle charges of misleading investors over probe into EpiPen Medicaid rebates

By Ed Silverman

Pharmalot

Up and down the ladder: The latest comings and goings

By Ed Silverman

Pharmalot

Pharmalittle: Opioid judge refuses to disqualify himself; Biocon to lower insulin price in some countries

By Ed Silverman

Pharmalot

Did someone say retraction? A dispute erupts over a paper about treating hyperthyroidism

By Ed Silverman

Pharmalot

FDA slams drug maker for not telling docs its sleeping pill is a controlled substance

By Ed Silverman

Pharmalot

Pharmalittle: House hearing on drug pricing descends into chaos, EMA tells drug makers to test for impurities

By Ed Silverman

Pharmalot

California reports pharma increased list prices way above inflation

By Ed Silverman

Pharmalot

U.K.’s Corbyn promises to form a government-owned drug company to lower prices

By Ed Silverman

Pharmalot

Pharmalittle: Drug pricing overhaul appears less likely; FDA to review drug given accelerated approval

By Ed Silverman

Pharmalot

U.K. regulator supports off-label use of the Avastin cancer drug for a serious eye condition

By Ed Silverman

Pharmalot

FTC warns lawyers about deceptive ads for generating lawsuits over drug side effects

By Ed Silverman

Pharmalot

Novartis unit says FDA wasn’t told of data manipulation sooner because it was ‘highly complex’

By Ed Silverman

Pharmalot

Pharmalittle: Pelosi plan rests with Dems who get big pharma bucks; Novartis recalls heartburn meds from U.S.

By Ed Silverman

Pharmalot

Novartis expands recall of heartburn meds to U.S. after finding carcinogen

By Ed Silverman

Pharmalot

Catalyst stock dives, although the fledgling drug maker has no idea why

By Ed Silverman

Pharmalot

Antibiotic resistance in food-producing animals surges in low- and middle-income countries

By Ed Silverman

Pharmalot

Pharmalittle: More countries restrict heartburn meds; Novartis battles Belgium over gene therapy for a toddler

By Ed Silverman

Pharmalot

More countries are banning or restricting sales of Zantac and other heartburn meds

By Ed Silverman

Pharmalot

Sun Pharma shipped medicines into Alabama for two years without a permit

By Ed Silverman

Pharmalot

Generic makers claim Medicare Part D plans crowd them out, hurting seniors

By Ed Silverman

Pharmalot

Up and down the ladder: The latest comings and goings

By Ed Silverman

Pharmalot

Pharmalittle: McConnell says House drug bill is dead on arrival; Purdue wants to pay bonuses

By Ed Silverman

Pharmalot

Pharmalittle: Pelosi unveils aggressive drug pricing plan; Novartis says baby death not related to gene therapy

By Ed Silverman

Judge tosses whistleblower suits alleging Lilly and Bayer used nurse educators to push drugs

FDA challenges testing used by lab that found a carcinogen in Zantac and other heartburn meds

Pharmalittle: Trump to name Hahn to head FDA; J&J settles opioid suit brought by Ohio counties

Pharmalittle: A novel plan to settle opioid suits; AstraZeneca COPD drug gets thumbs-down

Pharmalittle: Step forward for ovarian cancer drugs; Pelosi’s drug pricing plan could hit hospitals hard

Avanir to pay $116 million to settle bribery charges, while two docs and former sales reps are indicted

Mylan pays $30 million to settle charges of misleading investors over probe into EpiPen Medicaid rebates

Up and down the ladder: The latest comings and goings

Pharmalittle: Opioid judge refuses to disqualify himself; Biocon to lower insulin price in some countries

Did someone say retraction? A dispute erupts over a paper about treating hyperthyroidism

FDA slams drug maker for not telling docs its sleeping pill is a controlled substance

Pharmalittle: House hearing on drug pricing descends into chaos, EMA tells drug makers to test for impurities

California reports pharma increased list prices way above inflation

U.K.’s Corbyn promises to form a government-owned drug company to lower prices

Pharmalittle: Drug pricing overhaul appears less likely; FDA to review drug given accelerated approval

U.K. regulator supports off-label use of the Avastin cancer drug for a serious eye condition

FTC warns lawyers about deceptive ads for generating lawsuits over drug side effects

Novartis unit says FDA wasn’t told of data manipulation sooner because it was ‘highly complex’

Pharmalittle: Pelosi plan rests with Dems who get big pharma bucks; Novartis recalls heartburn meds from U.S.

Novartis expands recall of heartburn meds to U.S. after finding carcinogen

Catalyst stock dives, although the fledgling drug maker has no idea why

Antibiotic resistance in food-producing animals surges in low- and middle-income countries

Pharmalittle: More countries restrict heartburn meds; Novartis battles Belgium over gene therapy for a toddler

More countries are banning or restricting sales of Zantac and other heartburn meds

Sun Pharma shipped medicines into Alabama for two years without a permit

Generic makers claim Medicare Part D plans crowd them out, hurting seniors

Up and down the ladder: The latest comings and goings

Pharmalittle: McConnell says House drug bill is dead on arrival; Purdue wants to pay bonuses

Pharmalittle: Pelosi unveils aggressive drug pricing plan; Novartis says baby death not related to gene therapy